Overview

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Status:
Terminated

Trial end date:
2018-04-01

Target enrollment:

Participant gender:

Summary

ICLL01 The BOMP trial: Phase II study of salvage treatment with Bendamustine, Ofatumumab and MethylPrednisolone (BOMP) in relapsed B-cell chronic lymphocytic leukemia (B-CLL). A study of the GOELAMS / GCFLLC-MW intergroup

Phase:

Phase 2

Details

Lead Sponsor:

French Innovative Leukemia Organisation

Treatments:

Antibodies, Monoclonal
Bendamustine Hydrochloride
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate